Alfacalcidol

What is Alfacalcidol?

Alfacalcidol is a synthetic vitamin D analog, classified as an activated vitamin D derivative. It is converted by the liver into calcitriol, the active form of vitamin D, without requiring activation by the kidneys.

Alfacalcidol is approved and commonly prescribed for the management of:

• Renal osteodystrophy (bone disease associated with chronic kidney disease)
• Hypoparathyroidism and pseudohypoparathyroidism
• Rickets and osteomalacia, including vitamin D-resistant forms
• Osteoporosis, in certain clinical settings

Available formulations typically include:

• Oral capsules (various strengths, such as 0.25 mcg and 1 mcg)
• Oral drops (liquid solution)
• Injectable solution (for intravenous use, typically in dialysis settings)

The specific formulation and strength prescribed depends on the patient’s condition, kidney function, and specialist recommendation.

Common Prescribed Uses

• Managing mineral and bone disorders in chronic kidney disease, including in dialysis patients
• Treating low calcium levels related to parathyroid gland dysfunction
• Supporting bone health in certain metabolic bone conditions

What is the Recommended Dosage of Alfacalcidol?

Dosage of alfacalcidol is individualized and depends on several factors, including:

• The underlying condition being treated
• Patient age and body weight
• Kidney function, since impaired kidney function is often the reason alfacalcidol is prescribed instead of standard vitamin D
• Baseline and ongoing blood calcium, phosphate, and parathyroid hormone (PTH) levels
• Response to initial therapy, as monitored through regular lab testing

Because alfacalcidol directly raises active vitamin D levels, dosing requires close specialist supervision to avoid excessive calcium absorption.

This page does not provide specific dosing instructions. Patients should always follow the dosage prescribed by their treating specialist and should not adjust their dose without medical guidance.

Available dosage forms (capsule, drops, injection) allow specialists to tailor treatment based on the patient’s condition, age, and ability to take oral medication.

How Alfacalcidol Works

Normally, the body activates vitamin D through a two-step process involving the liver and kidneys. In people with reduced kidney function, this second activation step is impaired, leading to lower levels of active vitamin D.

Alfacalcidol bypasses the kidney’s role in this process. It only requires activation by the liver, allowing the body to produce active vitamin D even when kidney function is significantly reduced.

Active vitamin D helps the body absorb calcium from the digestive tract and supports normal bone mineralization and parathyroid hormone regulation.

Alfacalcidol does not cure the underlying kidney or parathyroid condition. It is a management tool used to help correct or prevent complications related to vitamin D and calcium deficiency.

Is a Prescription Required to Buy Alfacalcidol Online?

Yes. Alfacalcidol is a prescription-only medication in most regions. It should only be used under the supervision of a licensed medical specialist, such as a:

• Nephrologist (for kidney-related bone and mineral disorders)
• Endocrinologist (for parathyroid or general metabolic bone conditions)

Before starting alfacalcidol, patients should have:

• A confirmed diagnosis requiring active vitamin D therapy
• Baseline blood work, including calcium, phosphate, and kidney function tests
• An individualized treatment and monitoring plan established by their specialist

Important safety notes:

• Only purchase alfacalcidol from licensed, verified pharmacies.
• Avoid unregulated online sellers, as counterfeit or substandard products may not contain the correct dose or ingredients.
• Never use veterinary or non-human-grade vitamin D products intended for other purposes.

Side Effects of Alfacalcidol

Common Side Effects

These are usually mild and may improve as the body adjusts, or as dosing is fine-tuned:

• Nausea
• Loss of appetite
• Headache
• Dry mouth
• Mild digestive upset

Serious Side Effects

Although less common, some side effects require prompt medical attention:

• Signs of high blood calcium (hypercalcemia), such as confusion, unusual tiredness, muscle weakness, bone pain, excessive thirst, or increased urination
• Irregular heartbeat
• Signs of kidney problems, such as significant changes in urination
• Allergic reaction symptoms, such as rash, itching, swelling, or difficulty breathing

Seek immediate medical attention if any serious symptoms occur. This list is not exhaustive; patients should discuss their full side effect profile with their treating specialist.

Drug Interactions

Alfacalcidol can interact with a number of other substances, potentially increasing the risk of side effects such as high calcium levels. Interaction categories include:

• Other vitamin D supplements or analogs, which can compound effects and raise the risk of hypercalcemia
• Calcium-containing products, including antacids and calcium supplements
• Certain diuretics (particularly thiazide-type), which may increase calcium levels
• Digoxin and other heart medications, due to increased risk of irregular heartbeat if calcium levels rise
• Corticosteroids, which may reduce the effectiveness of vitamin D therapy
• Certain anticonvulsant medications, which may affect vitamin D metabolism
• Over-the-counter (OTC) medications, including some antacids and laxatives containing magnesium or calcium
• Herbal or dietary supplements, particularly those containing calcium or vitamin D

Patients should provide their treating specialist and pharmacist with a complete and updated list of all prescription medications, OTC products, vitamins, and herbal supplements they are taking to help avoid harmful interactions.

Safety & Important Considerations

• Kidney and liver considerations: Alfacalcidol requires liver activation and is often used specifically because of impaired kidney function; dosing must be closely supervised by a specialist familiar with the patient’s organ function.
• Pregnancy and breastfeeding: Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their specialist before use.
• Age-related considerations: Use in infants, children, and elderly patients requires individualized dosing and closer monitoring due to differences in calcium regulation.
• Monitoring requirements: Regular blood and urine tests are typically required to monitor calcium, phosphate, and kidney function during treatment, especially during dose adjustments.
• Risk of hypercalcemia: Long-term use requires careful monitoring, as excessive active vitamin D can lead to elevated calcium levels affecting the heart, blood vessels, and kidneys.
• Patients should not use this medication for purposes other than its approved use without specialist guidance.

Who This Medication Is For

Alfacalcidol is generally prescribed for individuals with conditions that impair the body’s natural ability to activate vitamin D or regulate calcium, including patients with chronic kidney disease (including those on dialysis), hypoparathyroidism, and certain metabolic bone disorders.

It is used as part of a broader, specialist-supervised treatment plan aimed at correcting vitamin D and calcium imbalances and supporting bone health.

Who Should Not Take Alfacalcidol

Alfacalcidol may not be appropriate for individuals with:

• Hypercalcemia (existing high blood calcium levels)
• Vitamin D toxicity
• Known hypersensitivity or allergy to alfacalcidol or any of its ingredients
• Certain conditions involving abnormal calcium metabolism, unless specifically directed by a specialist

Patients with a history of kidney stones, certain heart conditions, or those taking medications that affect calcium levels should discuss these factors carefully with their specialist before starting treatment.

This is not a complete list of contraindications. A full medical history review by a licensed specialist is required before starting therapy.

What to Do If You Miss a Dose

If a dose is missed, general guidance includes:

• Take the missed dose as soon as remembered, unless it is close to the time of the next scheduled dose.
• Do not double up on doses to make up for a missed one.
• If there is uncertainty about what to do, patients should contact their treating specialist or pharmacist for personalized guidance.

Related medications to Alfacalcidol

Other medications in the same therapeutic class (activated vitamin D analogs) may be considered by a specialist, depending on individual patient needs. These may include:

• Calcitriol
• Cinacalcet

Each alternative has a different potency, dosing schedule, and side effect profile depending on the patient’s overall health and kidney function. Switching between vitamin D analogs should only be done under the guidance of a nephrologist or endocrinologist, based on a full clinical evaluation.

Storage Instructions

• Store at room temperature, away from excess heat.
• Protect from moisture and direct light; avoid storing in bathrooms or humid areas.
• Keep capsules or drops in their original, tightly closed container.
• Store out of reach of children and pets, ideally in a secured location.
• Do not use medication that is expired or appears discolored; consult a pharmacist regarding proper disposal.

Disclaimer:

This page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult a licensed nephrologist, endocrinologist, or other relevant medical specialist before starting, changing, or stopping treatment with alfacalcidol. Treatment decisions must be based on a full clinical evaluation by a qualified specialist, taking into account individual health history, current lab values, and other medications.